# A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study

> **NCT01822639** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 15 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** GSK2944404 FDC
- **DRUG:** Amlodipine 5 mg
- **DRUG:** Enalapril Maleate 20 mg

## Key facts

- **NCT ID:** NCT01822639
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-03
- **Primary completion:** 2013-05-24
- **Final completion:** 2013-05-24
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01822639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01822639, "A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT01822639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*